Creso Pharma has appointed Legalise Cannabis WA MP Dr Brian Walker as a strategic consultant and chair of its new Scientific Advisory Committee.
The committee has been formed to expand the company’s pharmaceutical expertise and accelerate R&D, product development and clinical trials ahead of a potential NASDAQ listing.
Dr Walker will oversee and provide input into Creso’s medicinal cannabis, hemp and psychedelic products.
He will work across all the firm’s divisions including wholly owned Canadian subsidiary Mernova, psychedelics arm Halucenex Life Sciences and its Swiss operation.
As well as his role as an MP, Dr Walker is a board member of Mind Medicines Australia, the industry body focused on expanding the options available to medical practitioners using psychedelic-assisted treatments.
He said: “Over the course of my career, I have always advocated for the use of medicinal cannabis and psychedelics as alternative treatments and this role will provide another avenue to broaden awareness of their benefits.”
Creso non-executive chairman Adam Blumenthal added: “Brian’s passion and knowledge of the scientific and pharmaceutical advantages of cannabis and hemp products will assist us in a number of efforts, including R&D, product development and access to a range of other specialists and industry leaders to round out the committee.”